Efthymios Makis Deliargyris

Chief Medical Officer @CytoSorbents Corporation

Princeton, NJ, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

May 2020 — Present

Chief Medical Officer @CytoSorbents Corporation

View department →

NJ, US

EDUCATION

1985 — 1991

Ethnikon kai Kapodistriakon Panepistimion Athinon

Doctor of Medicine (M.D.)

1992 — 1997

Tufts University School of Medicine

Board Certification in Internal Medicine

1997 — 2001

The University of North Carolina at Chapel Hill

Board Certification in Cardiology & Interventional Cardiology

SKILLS

Clinical TrialsAtherosclerosisInternal MedicinePlaque RegressionMedical AffairsPublicationsMedical EducationLife SciencesMedical WritingBusiness IntelligenceMedical ImagingStrategic PartnershipsBiotechnologyMedical DevicesClinical ResearchHealthcareBusiness DevelopmentPcsk9 InhibitionU.s. Food and Drug Administration (Fda)Interventional CardiologyInvasive Vascular ImagingMedicinePharmacovigilanceHospitalsBusiness StrategyAdvisory BoardsRegistriesPharmaceutical IndustryFdaDrug SafetyBig Data AnalyticsCardiologyDrug DevelopmentStatistics

ABOUT EFTHYMIOS MAKIS DELIARGYRIS

Life sciences executive with deep scientific expertise in acute cardiovascular and critical care, a global academic footprint and successful track record in clinical development and commercialization.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Efthymios Makis Deliargyris — Chief Medical Officer at CytoSorbents Corporation in Princeton, NJ, US | Unifers